BMY vs GBDC · P/E 17, rev $24.46B vs P/E 16, $3.22B cap
Bristol-Myers Squibb Company (BMY) versus Golub Capital BDC Inc (GBDC) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Golub Capital BDC Inc (GBDC) is a asset management company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
GBDC does not have a complete income-statement cache yet.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GBDC currently screens at market cap $3.22B and trailing P/E 16.0.
Not investment advice. Open the BMY and GBDC stock pages for the full models.
Not investment advice.